FDA Approves AMRA Profiler Diagnosing Full Body Composition Through MRI
FDA has granted the approval to AMRA Medical—a Sweden-based company—for bringing in its innovative analytical technology, AMRA Profiler technology, for the analysis of fat and muscle composition in the body. The whole process involves a six-minute MRI scan and the imaging reports generated through scanning being forwarded to AMRA’s servers. After processing, AMRA delivers back the analyzed reports to medical doctors as well as patients.
The AMRA Profiler is the first diagnostics software that is able to translate the MRI-based data into a high-quality 3D fat and muscle sketch along with demonstrating the metabolic condition of the body. The technology analyzes the subcutaneous adipose tissue volume, visceral adipose tissue volume, thigh muscle volume, and liver fat fraction; and generates the report in the form of visual data and values-based information.
The AMRA profiler can be able to process the specific MRI reports that are generated through a compatible MRI scanner. AMRA collaborates with providers to confirm if the offering is installed, which prevents multiple communication steps within the process and deliver the patients’ accurate diagnostic reports.
Eric Converse—CEO of AMRA Medical—stated that the company is pleased with the FDA’s judgment. Well-organized documentation is formed of challenges faced by the health care systems. Along with this, society has also been facing various issues including aging population, obesity, and many more; and has been creating additional pressure on hospitals and clinics. He added in the statement that AMRA profiler would better deal with such challenges by thoroughly revealing the patient’s body composition to the physicians by least disturbing the patient.
The approval granted by FDA has offered a great opportunity to AMRA by interpreting the advantages of innovative offering in clinical observations and eventually supporting the authentic data and evidence that are highly responsible for making decisions regarding health care at present.